Acs Dobfar Spa Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACS DOBFAR SPA, and what generic and branded alternatives to ACS DOBFAR SPA drugs are available?
ACS DOBFAR SPA has nine approved drugs.
Summary for Acs Dobfar Spa
US Patents: | 0 |
Tradenames: | 6 |
Ingredients: | 6 |
NDAs: | 9 |
Drug Master File Entries: | 84 |
Drugs and US Patents for Acs Dobfar Spa
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Acs Dobfar Spa | ERTAPENEM SODIUM | ertapenem sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 208790-001 | Apr 16, 2018 | AP | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Acs Dobfar Spa | CEFUROXIME SODIUM | cefuroxime sodium | INJECTABLE;INTRAMUSCULAR, INTRAVENOUS | 064125-001 | May 30, 1997 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
Acs Dobfar Spa | AMPICILLIN SODIUM | ampicillin sodium | INJECTABLE;INJECTION | 090884-001 | Apr 3, 2013 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.